The ruling could end years of US litigation against Bayer over claims that Roundup weedkiller causes cancer, a legal battle inherited from Monsanto
A US judge has approved a $7.25 billion settlement by German chemical and pharmaceutical giant Bayer over claims that Roundup weedkiller causes cancer. The deal could bring an end to years of costly litigation involving tens of thousands of lawsuits.
Missouri Judge Timothy Boyer granted final approval to the deal on Friday. The nationwide settlement includes people who developed non-Hodgkin lymphoma, a type of blood cancer allegedly linked to Roundup exposure, as well as those who could be diagnosed in the future if they were exposed before February 17, 2026.
Under the deal, Bayer will pay up to $7.25 billion into a compensation fund over 21 years. Individual payouts are expected to average $10,000 to $165,000 depending on the patient’s age, severity of illness, and duration of exposure.
Judge Boyer described the deal as “among the largest in [the] history of mass tort personal-injury class action settlements.” He rejected objections from lawyers who deemed the compensation inadequate, saying further delays could leave seriously ill claimants waiting years for payments. Bayer CEO Bill Anderson welcomed the ruling as “a decisive milestone” in the company’s struggle to mitigate the risks of Roundup litigation.
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: rt.com










